- Home
- MREO vs NAN Comparison
MREO vs NAN Comparison
Compare MREO & NAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- NAN
- Stock Information
- Founded
- MREO 2015
- NAN 1999
- Country
- MREO United Kingdom
- NAN United States
- Employees
- MREO N/A
- NAN N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- NAN Investment Managers
- Sector
- MREO Health Care
- NAN Finance
- Exchange
- MREO Nasdaq
- NAN Nasdaq
- Market Cap
- MREO 326.1M
- NAN 337.8M
- IPO Year
- MREO N/A
- NAN N/A
- Fundamental
- Price
- MREO $1.97
- NAN $11.46
- Analyst Decision
- MREO Strong Buy
- NAN
- Analyst Count
- MREO 5
- NAN 0
- Target Price
- MREO $7.40
- NAN N/A
- AVG Volume (30 Days)
- MREO 1.3M
- NAN 74.6K
- Earning Date
- MREO 11-11-2025
- NAN 01-01-0001
- Dividend Yield
- MREO N/A
- NAN 4.37%
- EPS Growth
- MREO N/A
- NAN N/A
- EPS
- MREO N/A
- NAN N/A
- Revenue
- MREO $500,000.00
- NAN N/A
- Revenue This Year
- MREO N/A
- NAN N/A
- Revenue Next Year
- MREO $72.16
- NAN N/A
- P/E Ratio
- MREO N/A
- NAN N/A
- Revenue Growth
- MREO N/A
- NAN N/A
- 52 Week Low
- MREO $1.47
- NAN $9.11
- 52 Week High
- MREO $4.72
- NAN $11.34
- Technical
- Relative Strength Index (RSI)
- MREO 57.79
- NAN 58.89
- Support Level
- MREO $1.94
- NAN $11.36
- Resistance Level
- MREO $2.12
- NAN $11.48
- Average True Range (ATR)
- MREO 0.11
- NAN 0.07
- MACD
- MREO 0.02
- NAN -0.02
- Stochastic Oscillator
- MREO 62.65
- NAN 52.63
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About NAN Nuveen New York Quality Municipal Income Fund
Nuveen New York Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal, New York State and New York City income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.